1. Home
  2. Research
  3. Research Groups
  4. Allergic diseases diagnosis and treatment

Allergic diseases diagnosis and treatment

Search for publications

Only original articles, editorials, guidelines.

  • Betancor D, Villalobos-Violan V, Antolin-Amerigo D, De Las Vecillas L, Cárdenas-Contreras R, Elices A, Gandolfo-Cano M, Lopez-Gonzalez P, Moro-Moro M, Núñez-Acevedo B, Pineda R, Reaño M, Robledo-Echarren T, Rosado-Ingelmo A, Gutierrez-Albaladejo N, Rubio-Perez M, Valverde-Monge M, Vazquez de la Torre M, Feliu-Vila A, Gabriela LZ, Martín-Arriscado C, Garcia-Moguel I, Dominguez-Ortega J.

    Tezepelumab effectiveness in aspirin-exacerbated respiratory disease: a real-world multicenter study.

    RESPIRATORY MEDICINE . 263: 109178-109178.

    [doi:10.1016/j.rmed.2026.109178]

  • Madrigal-Burgaleta R, Alvarez-Cuesta E, Brockow K, Caubet JC, Garvey LH, Guzman-Melendez A, Alvarez ML, Mayorga L, Vazquez-Revuelta P, Ansotegui IJ, Attanasi M, Aun MV, Bartra J, Bavbek S, Berges-Gimeno MP, Bernal-Rubio L, Boteanu C, Bustamante L, Caffarelli C, Chow TG, Fernandes BN, Giavina-Bianchi P, Khan D, Kuyucu S, Laguna JJ, Lambourne J, Li L, Marinho S, Mori F, Norton AE, Palma Pino V, Parisi CAS, Park HS, Powell E, Rebelo Gomes E, Romano A, Sanak M, Schrijvers R, Solano-Solares E, Tanno LK, Valluzzi RL, Villarreal-Gonzalez R, Watts TJ, White AA, Yamaguchi M.

    Standards for practical management of drug hypersensitivity reactions to intravenous drugs and proactive early allergy involvement before referral: A WAO Statement.

    World Allergy Organization Journal . 19(10): 101467-101467.

    [doi:10.1016/j.waojou.2026.101467]

  • Cabanero-Navalon MD, De Andrés-Martín A, Gil AA, Bracke C, Carrillo-Linares JL, Cos ML, Gasior M, Gil-Niño J, González-Granado LI, López Osle N, Robles-Marhuenda Á, Sánchez Martínez R, Sánchez-Ramón S, Soler-Palacin P, Solanich X, Torralba-Cabeza MÁ, Aparicio Tormo JR, Alsina L, Moral Moral P.

    Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

    Frontiers in Immunology . 17: 1897051-1897051.

    [doi:10.3389/fimmu.2026.1897051]

  • Rama TA, Gulen T, Brockow K, Bonadonna P, Sabato V, Grattan CE, Broesby-Olsen S, Altrichter S, Siebenhaar F, Walusiak-Skorupa J, González-de-Olano D.

    Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper.

    ALLERGY . 81(8): 2713-2725.

    [doi:10.1111/all.70344]

  • Sucre-Adrianza I, Caligaris H, Morales-Cabeza C, Navarro-Navarro P, Sánchez-Muñoz L, Pérez-Pons A, Henriques A, González-Tablas M, González-López O, Recuero M, Jara-Acevedo M, González-de-Olano D, Mollejo M, García-Montero A, Orfao A, Alvarez-Twose I.

    The REMA Score Revisited: An Optimized Algorithm for Early Prediction of Clonal Mast Cell Disease.

    ALLERGY . 81(8): 2792-2803.

    [doi:10.1111/all.70379]

  • García-Gutiérrez I, Ramirez-Mateo E, Mato-De Prada C, Solórzano-Zepeda C, Sánchez-García V, Hernando ME, Antolín-Amérigo D, De la Hoz-Caballer B.

    Grass Pollen Exposure in an Environmental Exposure Chamber vs Natural Exposure: A Clinical Comparison of Symptoms.

    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY . 36(4): 311-313.

    [doi:10.18176/jiaci.1166]

  • Perez DB, Valverde-Monge M, Rosado A, Gandolfo-Cano M, Echarren TR, Moro-Moro MDM, Martos MDMR, Pineda-Pineda R, Antolin-Amérigo D, Torrado I, de la Torre MV, Cardenas R, García-Moguel I, Domínguez-Ortega J.

    Benralizumab is effective in severe asthma with CRS, regardless of demographic and clinical basal outcomes.

    ALLERGOLOGIA ET IMMUNOPATHOLOGIA . 54(4): 162-166.

    [doi:10.15586/aei.v54i4.1449]

  • López-González P, Vázquez de la Torre M, García-Moguel I, Juárez Rodríguez C, Correa-Borit J, Gandolfo-Cano M, González-Cano B, Moro-Moro M, Rosado-Ingelmo A, González-de-Olano D, Domínguez-Ortega J.

    Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps: Simultaneous Response to Dupilumab.

    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY . 36(3): 239-242. Number of citations: 1

    [doi:10.18176/jiaci.1150]

  • Rial MJ, Galván P, Antolín Amérigo D, Cárdenas-Contreras R, Montoro Ferrer A, Miralles López JC.

    Purinergic Receptors as Emerging Targets in the Management of Chronic Cough: From Pathophysiology to Clinical Application.

    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY . 36(3): 185-197.

    [doi:10.18176/jiaci.1170]

  • De La Morena-Barrio ME, Van Den Rym A, Escorial Sanz O, Corvillo F, García-Sánchez R, González-Sánchez L, Muñoz-Barrera A, González-Montelongo R, Lorenzo-Salazar JM, Flores C, De Andrés-Martín A, Rodríguez-Gallego C, Allende L, Alsina L, Sánchez-Ramón S, López-Collazo E, López-Trascasa M, Sánchez-Corral P, Pérez de Diego R, Corral de la Calle J, López-Lera A.

    Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogens.

    Frontiers in Immunology . 17: 1829115-1829115.

    [doi:10.3389/fimmu.2026.1829115]

  • Votto M, Rentzos G, Antolin-Amerigo D, Rymarczyk B, Konstantinou GN, Fox AT, Cianferoni A, Bakirtas A, Rossi CM, Tsoumani M, Heffler E, Terreehorst I, Apostolidou EC, Biló MB, Pfaar O, Lucendo AJ, Nikolopoulos GK, Pitsios C.

    Allergen Immunotherapy for the Treatment of Eosinophilic Esophagitis. An EAACI Task Force Systematic Review.

    Clinical and Translational Allergy . 16(6): .

    [doi:10.1002/clt2.70176]

  • Gálvez-Gafo L, Mariño-Sánchez F, Yeguas-Ramírez L, Muñoz-García M, Sánchez-Cuéllar S, Antolín-Amérigo D, González-de-Olano D, Santamaría-Gadea A.

    Evaluating mepolizumab and dupilumab for severe chronic rhinosinusitis with nasal polyps: insights from a real-life study.

    Acta Otorrinolaringologica Espanola . 77(3): 512328-512328.

    [doi:10.1016/j.otoeng.2026.512328]

  • Lozano-Espinosa M, Antolín-Amérigo D.

    Biological therapies in near-fatal asthma.

    Medicina Intensiva . 50(4): 502391-502391.

    [doi:10.1016/j.medine.2026.502391]

  • Martínez-Barros H, Muñoz-García M, Antolín-Amérigo D, Sánchez-Cuéllar S, Morales-Tirado A, de-Andrés-Martín A, De-Los-Santos-Granados G, Yeguas-Ramírez L, Blitz-Castro E, Santamaría-Gadea A, de-la-Hoz-Caballer B, Martín-Aragón S, González-de-Olano D, Álvarez-Díaz AM.

    [Translated article] Designing a patient onboarding in a multidisciplinary severe asthma unit.

    FARMACIA HOSPITALARIA . 50(1): .

    [doi:10.1016/j.farma.2025.10.009]

  • Calzada D, Parody N, Beitia JM, Dominguez-Ortega J, Gonzalez-de-Olano D, Renshaw-Calderón A, Osuna C, Moya R, Carnés J.

    Immunological Parameters for Assessing the In Vitro Safety and Efficacy of Allergoid Mixtures for Immunotherapy.

    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY . 35(6): 441-451. Number of citations: 1

    [doi:10.18176/jiaci.1061]

  • Antolín-Amérigo D, de Las Vecillas L, Alvarez-Perea A, Núñez-Acevedo B, González Moreno A, Rodríguez Jiménez B, Zambrano Ibarra G, Esteban-Gorgojo I, Vázquez Cortés S, Macías Iglesias J, Sánchez-Moreno V, Chivato T.

    Competent Allergists Facing the Challenges of the 21st Century: Multidisciplinary Management, Commitment to Excellence, Effective Communication, and Quality Teaching.

    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY . 36(1): 0-0.

    [doi:10.18176/jiaci.1119]

  • Korošec P, González-de-Olano D, Lyons JJ.

    Alpha-Tryptase Overexpression as a Modifier of Mast Cell-Mediated Reactions

    Journal of Allergy and Clinical Immunology-In Practice . 13(12): 3180-3186. Number of citations: 5

    [doi:10.1016/j.jaip.2025.10.018]

  • Rossi CM, Terreehorst I, Apostolidou E, Votto M, Bakirtas A, Cianferroni A, Konstantinou GN, Pantavou K, Antolin-Amerigo D, Heffler E, Alvarez-Perea A, Fernandez-Rivas M, Nikolopoulos GK, Pfaar O, Pitsios C.

    A Systematic Review and Meta-Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report

    ALLERGY . : . Number of citations: 12

    [doi:10.1111/all.70183]